Does Angiotensin Ii Interact with Polyethylene Glycol 3350 Sodium Chloride Potassium Chloride ?
CDI records a moderate classification for Angiotensin Ii and Polyethylene Glycol 3350 Sodium Chloride Potassium Chloride . The stored summary is: ACE inhibitors increase risk of fluid and electrolyte abnormalities when used with this drug combination. Use caution and consider additional patient evaluations. The mechanism involves fluid and electrolyte changes. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Angiotensin Ii Class
- Vasoconstrictor
- Polyethylene Glycol 3350 Sodium Chloride Potassium Chloride Class
- Osmotic Laxative
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Fluid and electrolyte changes
What To Tell Your Doctor or Pharmacist
If you are taking Angiotensin Ii and your doctor is considering prescribing Polyethylene Glycol 3350 Sodium Chloride Potassium Chloride (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider